Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2010 Sep 8;48(11):4263–4265. doi: 10.1128/JCM.01724-10

Novel Use of Tryptose Sulfite Cycloserine Egg Yolk Agar for Isolation of Clostridium perfringens during an Outbreak of Necrotizing Enterocolitis in a Neonatal Unit

Despina Kotsanas 1,*, Jolene A Carson 2, Milena M Awad 4, Dena Lyras 4, Julian I Rood 4, Grant A Jenkin 1,4, Rhonda L Stuart 1,5, Tony M Korman 1,3
PMCID: PMC3020804  PMID: 20826643

Abstract

Clostridium perfringens has been associated with necrotizing enterocolitis (NEC), which is a serious disease of neonates. Our study describes the novel use of selective tryptose sulfite cycloserine with egg yolk agar (TSC-EYA) during a nursery outbreak. This medium provides a rapid, sensitive, and accurate presumptive identification of C. perfringens.


Necrotizing enterocolitis (NEC) is the most common acquired disease affecting the gastrointestinal system of neonates, with low-birth-weight babies at highest risk (20, 22). Clinical features of NEC range from mild intestinal signs such as abdominal distension (stage 1), to radiological signs of pneumatosis (stage 2), to advanced disease (stage 3) involving severe abdominal distension, hypotension, and peritonitis (1, 20). The underlying pathophysiology of NEC is poorly understood but is likely to be secondary to multiple injuries to the neonate gut through hypoxia-ischemia, hyperosmolar feeds, and infection (20, 24).

No single infectious agent has been consistently identified as a cause of NEC, but Enterobacteriaceae (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae), viruses (rotavirus, coronavirus, echovirus, norovirus), and clostridial species have all been implicated (4, 23, 25, 30). The pathology of NEC resembles gas gangrene of the intestine caused by Clostridium perfringens, which produces a range of extracellular toxins (10, 11, 19, 27), and colonization with C. perfringens has been shown to be associated with both sporadic and nursery outbreaks of NEC (2-4). However, it is unclear whether C. perfringens is the causative agent of NEC or a marker of intestinal changes associated with the disease (2, 3, 16).

Culture for C. perfringens is not usually undertaken for neonatal feces, as C. perfringens is considered a part of the normal fecal flora, with up to 35% of preterm neonates colonized within the first 2 weeks of life (2, 30). In addition, isolation using conventional media such as horse blood agar (HBA), if required, is difficult without the use of selective supplements (2, 17). However, C. perfringens is also a major cause of human food poisoning, and when implicated in food-borne outbreaks, the causative bacterium can be recovered and enumerated by the use of highly selective media such as tryptose sulfite cycloserine agar, which provides a rapid presumptive morphological identification of C. perfringens (6, 8, 9, 31).

The neonatal unit at Monash Medical Centre has the capacity for 50 neonates and includes 18 level III (ventilated) neonatal intensive care unit (NICU) beds. The unit has a stable background NEC rate of about 6/1,000 admissions per year. From 1 January to 30 June 2008, 15 neonates were diagnosed with NEC (modified Bell stage 2 and above), increasing the yearly rate to 32/1,000 admissions and raising concerns of an outbreak. Cases were defined as neonates who met the NEC stage 2 or 3 criteria, and controls were defined as current neonates who were in the unit without NEC at the peak June outbreak period (1).

Fecal samples were collected from 11 neonates with NEC and 45 without NEC (current controls) from 6 to 20 June 2008. Microbiological investigations were undertaken for possible bacterial and viral pathogens (28).

Fecal samples (n = 56) were also cultured for C. perfringens using HBA (Oxoid CM 0331) and incubated for 48 h at 35°C in anaerobic jars. Colonies were examined for anaerobic hemolytic Gram-positive rods. Presumptive identification of C. perfringens was determined by using the reverse CAMP test (RC) (7, 12, 13). All isolates exhibiting hemolysis were confirmed using the RapID ANA II panel (Remel, Kansas) and by 16S rRNA gene sequencing.

Fecal samples were also directly cultured on tryptose sulfite cycloserine with egg yolk agar (TSC-EYA), which consisted of perfringens agar base (CM0587; Oxoid) with 5% egg yolk emulsion and d-cycloserine, for 24 h at 35°C (Media Preparation Unit, University of Melbourne) (5, 9, 14, 15). Black, lecithinase-positive or -negative colonies were presumptively identified as C. perfringens and confirmed as described above. To aid in the recovery of clostridia from a background mixture of bacteria, fecal samples were also heat shocked at 60°C for 20 min and then cultured on TSC-EYA (17). Since some C. perfringens isolates are known to be heat sensitive, a third method was used whereby samples were pretreated with ethanol for 1 h before being cultured on TSC-EYA (17, 18, 21).

All phenotypically black colonies that exhibited lecithinase activity and were RC positive underwent 16S rRNA gene sequence analysis and multiplex PCR toxinotyping. The preparation of genomic DNA from clostridial isolates and multiplex PCR including primer pair sequences used for genotyping were done as previously described (26, 29).

Direct inoculation onto TSC-EYA, which identified four more culture-positive neonates than did standard culture on HBA, was the most sensitive method examined (Table 1). Both heat shock and ethanol shock were less effective approaches for the isolation of C. perfringens than direct plating on TSC-EYA. No positive results were found by other methods using neonate samples that were negative on TSC-EYA. Direct plating on TSC-EYA was also rapid, saving 24 to 48 h compared to standard culture on HBA. In total, C. perfringens was isolated using TSC-EYA from 10 of 56 (18%) of the study subjects: 3 of 11 (27%) NEC cases and 7 of 45 (16%) controls (odds ratio [OR], 1.69; P = 0.46).

TABLE 1.

Clostridium perfringens isolated from neonatal fecal samples

Neonate Sample date (day/mo/yr) No. of samples with isolation of C. perfringensa
Standard method on HBA Direct method on TSC-EYA Heat shock method on TSC-EYA Ethanol shock method on TSC-EYA
Cases
    1 11/06/2008 D D D D
    2 19/06/2008 ND D D D
    3 27/06/2008 D D ND ND
Controls
    1 18/06/2008 D D ND D
    2 18/06/2008 D D ND D
    3 20/06/2008 D D ND D
    4 18/06/2008 D D ND ND
    5 18/06/2008 ND D D D
    6 18/06/2008 ND D D ND
    7 18/06/2008 ND D D D
Total recovered 6 10 5 7
a

TSC-EYA, tryptose sulfite cycloserine with egg yolk agar; HBA, horse blood agar; D, detected; ND, not detected. Total number of samples, 56.

Multiplex PCR toxinotype analysis revealed that all C. perfringens isolates were type A, with the plc gene, which encodes alpha-toxin, being the only major typing toxin gene detected (data not shown).

Four other isolates that were reverse CAMP positive, produced black colonies, or were lecithinase positive on TSC-EYA were identified by clostridial 16S rRNA gene amplification and sequence analysis (Table 2).

TABLE 2.

Other Clostridium spp. recovered from neonatal fecal samples

Neonate Sample date (day/mo/yr) Isolate characteristicsa identified by:
Species identification
Standard method on HBA Direct method on TSC-EYA Heat shock method on TSC-EYA Ethanol shock method on TSC-EYA
Case 1 11/06/2008 ND B, L+(WL) B, L+(WL), RC+WH B, L+, RC+(WH) C. baratii
Control 1 18/06/2008 RC+(WH), BH BH, L+ (WL) ND BH, L+(WL), RC+(WH) C. sardiniense
Control 2 18/06/2008 ND ND B+, L, RC ND C. paraputrificum
Control 3 20/06/2008 ND ND BH, L+(WL), RC+(WH) BH, L+, RC+(WH) C. baratii
a

TSC-EYA, tryptose sulfite cycloserine with egg yolk agar; HBA, horse blood agar; RC, reverse CAMP test; B, black colonies (hydrogen sulfide production); L, lecithinase production on TSC-EYA; BH, beta-hemolysis on HBA; WL, weak lecithinase production on TSC-EYA; WH, weak hemolytic zone on sheep blood agar; +, positive; −, negative; ND, not detected.

The rate of NEC in the unit returned to normal background levels over the second half of 2008, with only one NEC case diagnosed in December 2008. The outbreak resolved with implementation of enhanced infection control measures, such as environmental cleaning, isolation, and cohorting (i.e., physically separating infected from uninfected neonates). An increased detection of norovirus was observed during this outbreak, but its etiological role in the pathogenesis of NEC has yet to be demonstrated (28).

In conclusion, our study sample numbers from this outbreak of NEC in a neonatal nursery are small, and a larger, multicenter study with prospective sampling needs to be conducted to establish if C. perfringens is a causative agent of NEC or a marker of intestinal changes preceding disease. However, direct inoculation of neonatal fecal samples onto TSC-EYA provides a sensitive, rapid, and accurate presumptive identification of C. perfringens and will facilitate recovery in future investigations.

Acknowledgments

Research in the Department of Microbiology, Monash University, was supported by grants from the Australian National Health and Medical Research Council.

There are no potential conflicts of interest.

Footnotes

Published ahead of print on 8 September 2010.

REFERENCES

  • 1.Bell, M. J., J. L. Ternberg, R. D. Feigin, J. P. Keating, R. Marshall, L. Barton, and T. Brotherton. 1978. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187:1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Blakey, J. L., L. Lubitz, G. L. Barnes, R. F. Bishop, N. T. Campbell, and G. L. Gillam. 1982. Development of gut colonisation in pre-term neonates. J. Med. Microbiol. 15:519-529. [DOI] [PubMed] [Google Scholar]
  • 3.Blakey, J. L., L. Lubitz, N. T. Campbell, G. L. Gillam, R. F. Bishop, and G. L. Barnes. 1985. Enteric colonization in sporadic neonatal necrotizing enterocolitis. J. Pediatr. Gastroenterol. Nutr. 4:591-595. [DOI] [PubMed] [Google Scholar]
  • 4.Boccia, D., I. Stolfi, S. Lana, and M. L. Moro. 2001. Nosocomial necrotising enterocolitis outbreaks: epidemiology and control measures. Eur. J. Pediatr. 160:385-391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bridson, E. (ed.). 2006. The Oxoid manual, 9th ed. Oxoid Limited, Basingstoke, England.
  • 6.Brynestad, S., and P. E. Granum. 2002. Clostridium perfringens and foodborne infections. Int. J. Food Microbiol. 74:195-202. [DOI] [PubMed] [Google Scholar]
  • 7.Buchanan, A. G. 1982. Clinical laboratory evaluation of a reverse CAMP test for presumptive identification of Clostridium perfringens. J. Clin. Microbiol. 16:761-762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Byrne, B., A. G. M. Scannell, J. Lyng, and D. J. Bolton. 2008. An evaluation of Clostridium perfringens media. Food Control 19:1091-1095. [Google Scholar]
  • 9.de Jong, A. E., G. P. Eijhusen, E. J. Brouwer-Post, M. Grand, T. Johansson, T. Karkkainen, J. Marugg, P. H. in't Veld, F. H. Warmerdam, G. Worner, A. Zicavo, F. M. Rombouts, and R. R. Beumer. 2003. Comparison of media for enumeration of Clostridium perfringens from foods. J. Microbiol. Methods 54:359-366. [DOI] [PubMed] [Google Scholar]
  • 10.de la Cochetiere, M. F., H. Piloquet, C. des Robert, D. Darmaun, J. P. Galmiche, and J. C. Roze. 2004. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr. Res. 56:366-370. [DOI] [PubMed] [Google Scholar]
  • 11.Dittmar, E., P. Beyer, D. Fischer, V. Schafer, H. Schoepe, K. Bauer, and R. Schlosser. 2008. Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin. Eur. J. Pediatr. 167:891-895. [DOI] [PubMed] [Google Scholar]
  • 12.Gubash, S. M. 1980. Synergistic haemolysis test for presumptive identification and differentiation of Clostridium perfringens, C. bifermentans, C. sordellii, and C. paraperfringens. J. Clin. Pathol. 33:395-399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hansen, M. V., and L. P. Elliott. 1980. New presumptive identification test for Clostridium perfringens: reverse CAMP test. J. Clin. Microbiol. 12:617-619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Harmon, S. M., D. A. Kautter, and J. T. Peeler. 1971. Comparison of media for the enumeration of Clostridium perfringens. Appl. Microbiol. 21:922-927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Harmon, S. M., D. A. Kautter, and J. T. Peeler. 1971. Improved medium for enumeration of Clostridium perfringens. Appl. Microbiol. 22:688-692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hoy, C., M. R. Millar, P. MacKay, P. G. Godwin, V. Langdale, and M. I. Levene. 1990. Quantitative changes in faecal microflora preceding necrotising enterocolitis in premature neonates. Arch. Dis. Child. 65(10 Spec. No.):1057-1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Johnson, E., P. Summanen, and S. Finegold. 2007. Clostridium, p. 889. In P. R. Murray (ed.), Manual of clinical microbiology, 9th ed., vol. 1. ASM Press, Washington, DC. [Google Scholar]
  • 18.Koransky, J. R., S. D. Allen, and V. R. Dowell, Jr. 1978. Use of ethanol for selective isolation of sporeforming microorganisms. Appl. Environ. Microbiol. 35:762-765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kosloske, A. M., W. S. Ball, Jr., E. Umland, and B. Skipper. 1985. Clostridial necrotizing enterocolitis. J. Pediatr. Surg. 20:155-159. [DOI] [PubMed] [Google Scholar]
  • 20.Lin, P. W., and B. J. Stoll. 2006. Necrotising enterocolitis. Lancet 368:1271-1283. [DOI] [PubMed] [Google Scholar]
  • 21.Marler, L. M., J. A. Siders, L. C. Wolters, Y. Pettigrew, B. L. Skitt, and S. D. Allen. 1992. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J. Clin. Microbiol. 30:514-516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Neu, J. 2005. Neonatal necrotizing enterocolitis: an update. Acta Paediatr. Suppl. 94:100-105. [DOI] [PubMed] [Google Scholar]
  • 23.Obladen, M. 2009. Necrotizing enterocolitis—150 years of fruitless search for the cause. Neonatology 96:203-210. [DOI] [PubMed] [Google Scholar]
  • 24.Panigrahi, P. 2006. Necrotizing enterocolitis: a practical guide to its prevention and management. Paediatr. Drugs 8:151-165. [DOI] [PubMed] [Google Scholar]
  • 25.Peter, C. S., M. Feuerhahn, B. Bohnhorst, M. Schlaud, S. Ziesing, H. von der Hardt, and C. F. Poets. 1999. Necrotising enterocolitis: is there a relationship to specific pathogens? Eur. J. Pediatr. 158:67-70. [DOI] [PubMed] [Google Scholar]
  • 26.Pospiech, A., and B. Neumann. 1995. A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet. 11:217-218. [DOI] [PubMed] [Google Scholar]
  • 27.Rood, J. I. 1998. Virulence genes of Clostridium perfringens. Annu. Rev. Microbiol. 52:333-360. [DOI] [PubMed] [Google Scholar]
  • 28.Stuart, R., K. Tan, J. Mahar, C. Kirkwood, C. Ramsden, N. Andrianopoulos, D. Jolley, K. Bawden, R. Doherty, D. Kotsanas, and J. Buttery. 2010. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr. Infect. Dis. J. 29:644-647. [DOI] [PubMed] [Google Scholar]
  • 29.Uzal, F. A., and J. G. Songer. 2008. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest. 20:253-265. [DOI] [PubMed] [Google Scholar]
  • 30.Westra-Meijer, C. M., J. E. Degener, G. Dzoljic-Danilovic, M. F. Michel, and J. W. Mettau. 1983. Quantitative study of the aerobic and anaerobic faecal flora in neonatal necrotising enterocolitis. Arch. Dis. Child. 58:523-528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yurdakök, M. 2008. What next in necrotizing enterocolitis? Turk. J. Pediatr. 50:1-11. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES